Martin Bocks, MD
Pediatric Interventional Cardiology, Cardiology, Pediatric Cardiology
Accepting New Patients
Schedule an Appointment
- Director, Pediatric Cath Lab, UH Rainbow Babies and Children's Hospital
- Program Director, Pediatric Interventional Cardiology, UH Rainbow Babies and Children's Hospital
- Associate Professor, CWRU School of Medicine
Martin Bocks, MD, is the Director of Pediatric Interventional Cardiology at the Congenital Heart Collaborative and the Division of Pediatric Cardiology at UH Rainbow Babies & Children’s Hospital. He also has a secondary appointment within University Hospitals Harrington Heart & Vascular Institute.
Board-certified in pediatric cardiology and adult congenital heart disease, Dr. Bocks’ special interests include transcatheter pulmonary valve replacement, complex neonatal interventions, and endovascular therapies for congenital heart defects in children and adults. His research interests include pediatric medical device development with a particular emphasis on bioresorbable technologies for cardiac catheterization interventions and wireless implantable pressure monitors. He was named to the medical staff at UH Rainbow Babies & Children’s Hospital in 2016.
Dr. Bocks has published numerous papers in peer-reviewed medical journals on interventional therapies for congenital heart disease as well as numerous manuscripts in leading biomedical engineering journals for his work on medical device development. He serves as a reviewer for numerous leading periodicals in the field of congenital and structural heart interventions.
Dr. Bocks earned a Bachelor of Science degree in biology from the University of Michigan in Ann Arbor, Michigan, and his medical degree from Wayne State University School of Medicine in Detroit. As a medical student, he was inducted into the Alpha Omega Alpha Honor Medical Society. He completed a residency in internal medicine-pediatrics and fellowships in pediatric cardiology and pediatric interventional cardiology at the University of Michigan.
He is a fellow of the American College of Cardiology (FACC) and the Society for Cardiovascular Angiography and Intervention (FSCAI). His other professional memberships include the American Society of Artificial Internal Organs (ASAIO) and the Society for Pediatric Research (SPR).
- Bioresorbable Technologies
- Congenital Heart Defects
- Endovascular Therapies
- Pediatric Cardiac Catheterization
- Pediatric Medical Device Development
- Trans-Catheter Pulmonary Valve Implantation
UH Broadview Heights Health Center
5901 E Royalton Rd
Broadview Heights OH, 44147
UH North Ridgeville Health Center
32800 Lorain Rd
North Ridgeville OH, 44039
- Adult Congenital Heart Disease - American Board of Internal Medicine
- Pediatric Cardiology - American Board of Pediatrics
Fellowship | Pediatric Interventional Cardiology
Pediatric Interventional Cardiology - University Of Michigan Medical Center/University Of Michigan Health System (2007 - 2008)
Fellowship | Pediatric Cardiology
Pediatric Cardiology - University Of Michigan Medical Center/University Of Michigan Health System (2004 - 2007)
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - University Of Michigan Medical Center/University Of Michigan Health System (2000 - 2004)
Wayne State University School Of Medicine (2000)
University Of Michigan (1994)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Martin Bocks disclosed the following Outside Relationships with Industry:
- - Edwards Lifesciences - Consulting payments